About Teitur Trophics
Teitur Trophics is a company based in Aarhus (Denmark) founded in 2020 by Mathias Kaas Ollendorff, Simon Molgaard, Anders Dalby, and Simon Pedersen.. Teitur Trophics has raised $29.99 million across 2 funding rounds from investors including BioInnovation Institute, Sunstone and Sound Bioventures. The company has 10 employees as of November 30, 2024. Teitur Trophics offers products and services including Cyclic Peptides Therapeutics and Biomarker Development. Teitur Trophics operates in a competitive market with competitors including The Fertility Partners, George Institute, HD, Arialys and Novus Diagnostics, among others.
- Headquarter Aarhus, Denmark
- Employees 10 as on 30 Nov, 2024
- Founders Mathias Kaas Ollendorff, Simon Molgaard, Anders Dalby, Simon Pedersen
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Teitur Trophics Aps
-
Annual Revenue
-
Net Profit
$-523.28 K (USD)47as on Dec 31, 2022
-
EBITDA
-
Total Equity Funding
$29.99 M (USD)
in 2 rounds
-
Latest Funding Round
$29.99 M (USD), Series A
Mar 14, 2023
-
Investors
BioInnovation Institute
& 5 more
-
Employee Count
10
as on Nov 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Teitur Trophics
Teitur Trophics offers a comprehensive portfolio of products and services, including Cyclic Peptides Therapeutics and Biomarker Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapeutics targeting neurodegenerative diseases for improved patient outcomes.
Compounds for identifying and treating Huntington’s Disease effectively.
Unlock access to complete
Unlock access to complete
Funding Insights of Teitur Trophics
Teitur Trophics has successfully raised a total of $29.99M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $29.99 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $30.0M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Series A - Teitur Trophics | Valuation | Sunstone , Sound Bioventures | |
| Jun, 2020 | Amount | Seed - Teitur Trophics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Teitur Trophics
Teitur Trophics has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include BioInnovation Institute, Sunstone and Sound Bioventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by Sunstone in early-stage European companies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investment in early-stage technology, life science, and Health startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Teitur Trophics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Teitur Trophics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Teitur Trophics Comparisons
Competitors of Teitur Trophics
Teitur Trophics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as The Fertility Partners, George Institute, HD, Arialys and Novus Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Business consulting services for fertility practices are provided.
|
|
| domain | founded_year | HQ Location |
Medical research is conducted by the institute in health fields.
|
|
| domain | founded_year | HQ Location |
Medical information services are provided in the healthcare sector.
|
|
| domain | founded_year | HQ Location |
Precision medicines for autoimmune neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic information services for clinicians
|
|
| domain | founded_year | HQ Location |
Provider of medical information solutions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Teitur Trophics
Frequently Asked Questions about Teitur Trophics
When was Teitur Trophics founded?
Teitur Trophics was founded in 2020.
Where is Teitur Trophics located?
Teitur Trophics is headquartered in Aarhus, Denmark.
Who is the current CEO of Teitur Trophics?
Simon Molgaard is the current CEO of Teitur Trophics. They have also founded this company.
Is Teitur Trophics a funded company?
Teitur Trophics is a funded company, having raised a total of $29.99M across 2 funding rounds to date.
How many employees does Teitur Trophics have?
As of Nov 30, 2024, the latest employee count at Teitur Trophics is 10.
What does Teitur Trophics do?
Teitur Trophics was established in 2020 in Aarhus, Denmark, by co-founders Mathias Kaas Ollendorff, Simon Molgaard, Anders Dalby, and Simon Pedersen. Development services for therapeutics targeting neurodegenerative diseases are offered within the biotechnology sector. Operations emphasize research and innovation in treatment pipelines. The company maintains its headquarters in Denmark, supporting global efforts in health advancements through targeted therapeutic solutions.
Who are the top competitors of Teitur Trophics?
Teitur Trophics's top competitors include George Institute, The Fertility Partners and HD.
What products or services does Teitur Trophics offer?
Teitur Trophics offers Cyclic Peptides Therapeutics and Biomarker Development.
Who are Teitur Trophics's investors?
Teitur Trophics has 6 investors. Key investors include BioInnovation Institute, Sunstone, Sound Bioventures, Innovestor, and Industrifonden.